Rock Springs Capital Management LP - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q2 2023$6,948,897
-44.6%
341,637
-40.7%
0.16%
-44.8%
Q1 2023$12,546,816
-29.8%
576,6000.0%0.30%
-30.5%
Q4 2022$17,868,834
+21.5%
576,6000.0%0.43%
+13.2%
Q3 2022$14,709,000
+26.6%
576,600
+0.8%
0.38%
+12.4%
Q2 2022$11,618,000
-16.6%
572,300
+1.6%
0.34%
-3.7%
Q1 2022$13,936,000
-25.6%
563,300
+4.6%
0.35%
-18.9%
Q4 2021$18,720,000
+28.8%
538,700
+0.5%
0.43%
+41.5%
Q3 2021$14,532,000
+4.7%
535,832
+0.1%
0.31%
+11.7%
Q2 2021$13,879,000
+20.3%
535,2320.0%0.27%
+8.7%
Q1 2021$11,534,000
+73.4%
535,232
+73.0%
0.25%
+78.7%
Q4 2020$6,652,000
+45.9%
309,413
+0.1%
0.14%
+21.6%
Q3 2020$4,559,000
-33.5%
309,113
+0.8%
0.12%
-38.3%
Q2 2020$6,852,000
+61.6%
306,713
+2.2%
0.19%
+7.4%
Q1 2020$4,239,000
+93.2%
300,000
+122.2%
0.18%
+153.6%
Q4 2019$2,194,000
-73.9%
135,000
-43.8%
0.07%
-79.4%
Q3 2019$8,398,000
-31.9%
240,000
+9.8%
0.34%
-24.9%
Q2 2019$12,328,000
-0.7%
218,500
+28.5%
0.45%
-6.9%
Q1 2019$12,419,000
+43.2%
170,000
+25.0%
0.48%
+17.1%
Q4 2018$8,675,000
-47.3%
136,000
-17.6%
0.41%
-31.4%
Q3 2018$16,462,000
+54.5%
165,000
+10.0%
0.60%
+45.4%
Q2 2018$10,656,000
-24.2%
150,000
+11.1%
0.41%
-31.6%
Q1 2018$14,051,000
-2.0%
135,000
-5.2%
0.60%
-8.0%
Q4 2017$14,343,000
+173.6%
142,400
-5.1%
0.65%
+169.0%
Q3 2017$5,243,000150,0000.24%
Other shareholders
ANAPTYSBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders